Screener
Kairos Pharma KAPA Q4 2025 Annual earnings
Reported March 31, 2026
EPS-$0.07Miss by $0.05
EPS estimate-$0.02
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.09
Versus estimates
Diluted EPS
FAQ
- When did Kairos Pharma report Q4 2025 earnings?
- Kairos Pharma (KAPA) reported Q4 2025 earnings on March 31, 2026.
- What were Kairos Pharma's Q4 2025 revenue and EPS?
- Kairos Pharma reported eps of $-0.07 for Q4 2025.
- Did Kairos Pharma beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.02 by $0.05.
- How did Kairos Pharma's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 21.3% from $-0.09.
- Where can I find Kairos Pharma's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-014159) directly on SEC EDGAR. The filing index links above go to sec.gov.
